Target Name: LOC107986003
NCBI ID: G107986003
Review Report on LOC107986003 Target / Biomarker Content of Review Report on LOC107986003 Target / Biomarker
LOC107986003
Other Name(s): uncharacterized LOC107986003 | Uncharacterized LOC107986003

LOC107986003: A Potential Drug Target and Biomarker

LOC107986003 is a novel protein that has been identified as a potential drug target and biomarker. It is a member of the protein kinase C (PKC) family, which is a well-known signaling pathway that is involved in various cellular processes, including cell growth, differentiation, and survival. PKC signaling is a critical pathway that is involved in many physiological processes in the body, including the regulation of inflammation, pain, and motion.

LOC107986003 was identified as a potential drug target because it is involved in the regulation of cellular processes that are associated with various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. For example, LOC107986003 has been shown to be involved in the regulation of cell proliferation, migration, and survival, which are all key processes that are involved in the development and progression of many diseases.

In addition to its potential as a drug target, LOC107986003 has also been identified as a potential biomarker. This is because it is expressed in a variety of tissues and cells, including cancer cells, neurons, and immune cells. Additionally, LOC107986003 has been shown to be a protein that is targeted by several anti-cancer drugs, including inhibitors of the PKC pathway. This suggests that LOC107986003 may be a useful biomarker for the evaluation of the efficacy of anti-cancer drugs.

LOC107986003 is also a potential drug target because it is involved in the regulation of cellular processes that are involved in pain perception and neurodegenerative diseases. For example, LOC107986003 has been shown to be involved in the regulation of pain signaling, which is important for the development and progression of neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease.

In addition to its potential as a drug target and biomarker, LOC107986003 is also of interest because of its unique structure and mechanism of action. LOC107986003 is a 12 kDa protein that consists of a single polypeptide chain that is composed of 106 amino acids. It has a unique 21 amino acid insertion at its C-terminus that is responsible for its unique structure and function.

The unique insertion of the 21 amino acid at the C-terminus of LOC107986003 has several implications for its function. For example, it is possible that the insertion may have modified the protein's stability or stability, which could affect its ability to interact with other proteins and targets. Additionally, the insertion may have changed the way that LOC107986003 functions, such as its binding affinity or its function in cellular signaling pathways.

In conclusion, LOC107986003 is a novel protein that has the potential to be a drug target and biomarker. Its unique structure and mechanism of action, as well as its involvement in cellular signaling pathways, make it an attractive target for further research and development. Further studies, including biochemical, cellular, and animal models, are needed to determine the full extent of LOC107986003's potential as a drug target and biomarker.

Protein Name: Uncharacterized LOC107986003

The "LOC107986003 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC107986003 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC107986009 | LOC107986018 | LOC107986022 | LOC107986023 | LOC107986051 | LOC107986056 | LOC107986092 | LOC107986115 | LOC107986139 | LOC107986141 | LOC107986142 | LOC107986146 | LOC107986148 | LOC107986166 | LOC107986178 | LOC107986186 | LOC107986195 | LOC107986203 | LOC107986205 | LOC107986215 | LOC107986223 | LOC107986229 | LOC107986257 | LOC107986272 | LOC107986286 | LOC107986291 | LOC107986297 | LOC107986298 | LOC107986300 | LOC107986362 | LOC107986368 | LOC107986385 | LOC107986400 | LOC107986420 | LOC107986429 | LOC107986440 | LOC107986451 | LOC107986452 | LOC107986453 | LOC107986454 | LOC107986469 | LOC107986517 | LOC107986522 | LOC107986528 | LOC107986537 | LOC107986544 | LOC107986545 | LOC107986561 | LOC107986589 | LOC107986594 | LOC107986595 | LOC107986597 | LOC107986598 | LOC107986606 | LOC107986613 | LOC107986622 | LOC107986623 | LOC107986626 | LOC107986636 | LOC107986649 | LOC107986666 | LOC107986764 | LOC107986766 | LOC107986770 | LOC107986771 | LOC107986772 | LOC107986774 | LOC107986776 | LOC107986777 | LOC107986781 | LOC107986787 | LOC107986800 | LOC107986816 | LOC107986820 | LOC107986836 | LOC107986844 | LOC107986873 | LOC107986892 | LOC107986894 | LOC107986901 | LOC107986903 | LOC107986927 | LOC107986930 | LOC107986952 | LOC107986961 | LOC107986983 | LOC107986996 | LOC107987026 | LOC107987045 | LOC107987049 | LOC107987053 | LOC107987057 | LOC107987064 | LOC107987087 | LOC107987099 | LOC107987121 | LOC107987164 | LOC107987178 | LOC107987211 | LOC107987243